Panacur Equine Guard 100 mg/ml Oral Suspension

Care should be taken to avoid the following practices because they increase the risk
of development of resistance and could ultimately result in ineffective therapy:
•
extended period of time.
•
misadministration of the veterinary medicinal product, or lack of calibration of the
dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of
the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic
belonging to another pharmacological class and having a different mode of action
should be used.
Resistance to fenbendazole has been reported in cyathostomes in horses. Therefore,
the use of this veterinary medicinal product should be based on local (regional, farm)
epidemiological information about susceptibility of nematodes and recommendations
on how to limit further selection for resistance to anthelmintics.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Direct contact with the skin should be kept to a minimum. Personal protective
equipment consisting of impermeable rubber gloves and long sleeves should be worn
when handling the veterinary medicinal product. Remove and wash any
contaminated clothing immediately.
In case of accidental spillage onto skin, wash the affected area thoroughly with soap
and water.
Do not smoke, drink, or eat when handling the product.
Wash hands after use.
AN: 01390/2025 & 01391/2025
Special precautions for the protection of the environment:
Not applicable.